C12N 2710/10033
Use of viral protein as therapeutic agent other than vaccine
Official title: Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
C12N2710/10033 (Use of viral protein as therapeutic agent other than vaccine) appears on 19 US grants and 33 published applications in this corpus.
Search patents in C12N- Granted patents
- 19
- Published applications
- 33
- Assignees
- 22
- Inventors
- 54
- Latest grant
- 11 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 2 |
| 2015 | 0 | 1 |
| 2016 | 1 | 3 |
| 2017 | 1 | 3 |
| 2018 | 3 | 3 |
| 2019 | 2 | 7 |
| 2020 | 2 | 2 |
| 2021 | 3 | 4 |
| 2022 | 4 | 2 |
| 2023 | 1 | 2 |
| 2024 | 0 | 1 |
| 2025 | 2 | 1 |
By publication year.
Recent patents
- Desmoglein 2 (DSG2) binding proteins and uses therefor11 Nov 2025US 12,466,859 B2University of Washington through its Center for Commercialization
- Adeno-associated virus compositions for restoring PAH gene function and methods of use thereof21 Jan 2025US 12,203,094 B2Homology Medicines, Inc.
- Desmoglein 2 (DSG2) binding proteins and uses therefor21 Nov 2023US 11,820,795 B2University of Washington
- Oncolytic adenoviruses coding for bi-specific antibodies1 Nov 2022US 11,485,791 B2Tilt Biotherapeutics Oy
- Methods of treating cancer15 Mar 2022US 11,273,170 B2Ascend Biopharmaceuticals Ltd
- Adeno-Associated-Virus Rep Sequences, Vectors and Viruses23 Jan 2025US 2025/0027056 A1The Research Foundation for The State University of New York
- Desmoglein 2 (DSG2) Binding Proteins and Uses Therefor14 Mar 2024US 2024/0083953 A1University of Washington through its Center for Commercialization
- Oncolytic adenoviruses coding for bi-specific antibodies and methods and uses related thereto31 Aug 2023US 2023/0272108 A1Tilt Biotherapeutics Oy
- Structure of oncolytic virus comprising bispecific nucleic acid molecule27 Apr 2023US 2023/0127169 A1Curigin Co., Ltd.
- Adeno-associated virus compositions for restoring pah gene function and methods of use thereof13 Oct 2022US 2022/0325302 A1Homology Medicines, Inc.
Most cited
By later US patents
- Conditionally replicating adenovirus to express REIC gene9US 10,071,126 B2Industry-University Cooperation Foundation Hanyang University · 2018
- Decorin gene delivery system and cancer treatment8US 10,046,067 B2Genemedicine Co., Ltd. · 2018
- Desmoglein 2 (DSG2) binding proteins and uses therefor8US 10,150,798 B2University of Washington through its Center for Commercialization · 2018
- Desmoglein 2 (DSG2) binding proteins and uses therefor8US 10,611,803 B2University of Washington through its Center for Commercialization · 2020
- Desmoglein 2 (DSG2) binding proteins and uses therefor8US 9,688,727 B2University of Washington · 2017